Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Current Taxes (2020 - 2025)

Ironwood Pharmaceuticals (IRWD) has disclosed Current Taxes for 5 consecutive years, with $927000.0 as the latest value for Q4 2025.

  • Quarterly Current Taxes rose 77.93% to $927000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $927000.0 through Dec 2025, up 77.93% year-over-year, with the annual reading at $927000.0 for FY2025, 77.93% up from the prior year.
  • Current Taxes hit $927000.0 in Q4 2025 for Ironwood Pharmaceuticals, up from $656000.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $6.6 million in Q2 2023 to a low of $521000.0 in Q4 2024.
  • Historically, Current Taxes has averaged $1.4 million across 4 years, with a median of $931000.0 in 2024.
  • Biggest five-year swings in Current Taxes: surged 89.63% in 2023 and later plummeted 85.93% in 2024.
  • Year by year, Current Taxes stood at $656000.0 in 2022, then soared by 89.63% to $1.2 million in 2023, then plummeted by 58.12% to $521000.0 in 2024, then surged by 77.93% to $927000.0 in 2025.
  • Business Quant data shows Current Taxes for IRWD at $927000.0 in Q4 2025, $656000.0 in Q3 2025, and $764000.0 in Q2 2025.